[Present state of the multidisciplinary treatment of pancreatic carcinoma].
Though the resection rate of pancreatic carcinoma has become markedly higher since introduction of extensive operation in 1978, the prognosis is still poor, and a majority of resected cases die of tumor within one year after operation. It must be emphasized that the multidisciplinary treatment positively incorporating such new procedures as described below is now important to improve the therapeutic results of pancreatic carcinoma; providing a device for postoperative percutaneous intraarterial injection for resectable cases or performing local chemotherapy with MMC preparations of controlled release for non-resectable cases.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D010179:Pancreas / Q000473:pathology; D010180:Pancreatectomy / Q000401:mortality; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011379:Prognosis
D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D016685:Mitomycin